FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gentian Kristo

Research Profile

Chemicals & Drugs

Procedures

Myocardial Ischemic Preconditioning

Living Beings

Disorders

Anatomy

Myocardium

Co-author Network

Publications

TOP 3
Robert D Lasley; Gentian Kristo; Byron J Keith; Robert M Mentzer
The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium.
Cherry Ballard-Croft; Adam C Locklar; Gentian Kristo; Robert D Lasley
Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol.
Gentian Kristo; Yukihiro Yoshimura; Byron J Keith; Robert M Mentzer; Robert D Lasley
Aged rat myocardium exhibits normal adenosine receptor-mediated bradycardia and coronary vasodilation but increased adenosine agonist-mediated cardioprotection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gentian Kristo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Robert D Lasley; Gentian Kristo; Byron J Keith; Robert M Mentzer
The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium.
American journal of physiology. Heart and circulatory physiology 2007;292(1):H426-31.
2006: Cherry Ballard-Croft; Adam C Locklar; Gentian Kristo; Robert D Lasley
Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol.
American journal of physiology. Heart and circulatory physiology 2006;291(2):H658-67.
2005: Gentian Kristo; Yukihiro Yoshimura; Byron J Keith; Robert M Mentzer; Robert D Lasley
Aged rat myocardium exhibits normal adenosine receptor-mediated bradycardia and coronary vasodilation but increased adenosine agonist-mediated cardioprotection.
The journals of gerontology. Series A, Biological sciences and medical sciences 2005;60(11):1399-404.
2005: Robert D Lasley; Byron J Keith; Gentian Kristo; Yukihiro Yoshimura; Robert M Mentzer
Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent.
American journal of physiology. Heart and circulatory physiology 2005;289(2):H785-91.
2005: Easton A Reid; Gentian Kristo; Yukihiro Yoshimura; Cherry Ballard-Croft; Byron J Keith; Robert M Mentzer; Robert D Lasley
In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling.
American journal of physiology. Heart and circulatory physiology 2005;288(5):H2253-9.
2005: Cherry Ballard-Croft; Gentian Kristo; Yukihiro Yoshimura; Easton A Reid; Byron J Keith; Robert M Mentzer; Robert D Lasley
Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments.
American journal of physiology. Heart and circulatory physiology 2005;288(3):H1359-66.
2004: Gentian Kristo; Yukihiro Yoshimura; Byron J Keith; Randy M Stevens; Salik A Jahania; Robert M Mentzer; Robert D Lasley
Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning.
American journal of physiology. Heart and circulatory physiology 2004;287(6):H2746-53.
2004: Yukihiro Yoshimura; Gentian Kristo; Byron J Keith; Salik A Jahania; Robert M Mentzer; Robert D Lasley
The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):433-40.
2004: Gentian Kristo; Yukihiro Yoshimura; Suellen P Ferraris; Salik A Jahania; Robert M Mentzer; Robert D Lasley
The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
Journal of the American College of Surgeons 2004;199(4):586-94.
2004: Gentian Kristo; Yukihiro Yoshimura; Jianli Niu; Byron J Keith; Robert M Mentzer; Rolf Bünger; Robert D Lasley
The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium.
American journal of physiology. Heart and circulatory physiology 2004;286(2):H517-24.